On September 2, 2019, Kingdomway (002626) announced that the company and its wholly-owned subsidiary, Xiamen Kingdomway Biotech Co., Ltd., had recently received a patent certificate for invention issued by the State Intellectual Property Office. The purpose of the invention is to provide a water-soluble, excellent stability, high bioavailability of coenzyme-containing coenzyme Q10 self-microemulsion nutrition composition, which has a high degree of stability, significantly inhibited the coenzyme Q10 crystal, extended the shelf life of the product.
The patent information is as follows:
Invention Name: A self-microemulsion nutritional composition containing coenzyme Q10, preparation method and use
Patent Application Date: December 29, 2016
Patentee: Xiamen Kingdomway Biotech Co., Ltd., Xiamen Kingdomway Group Co., Ltd.
Patent term: 20 years
Authorization Announcement Date: August 16, 2019
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
